{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T19:04:25Z","timestamp":1782759865184,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01425-x","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T02:29:17Z","timestamp":1771813757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comprehensive Real-World Outcomes of Multimodal Treatment in Gallbladder Cancer: A Prospective Cohort Study"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-1299","authenticated-orcid":false,"given":"Kumar","family":"Vineet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piyush Kant","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Vadodaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd. Irfan","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurupreet Singh","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"issue":"4","key":"1425_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.21037\/cco.2019.08.03","volume":"8","author":"U Dutta","year":"2019","unstructured":"Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 2019;8(4):33. https:\/\/doi.org\/10.21037\/cco.2019.08.03.","journal-title":"Chin Clin Oncol"},{"key":"1425_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/CLEP.S37357","volume":"6","author":"R Hundal","year":"2014","unstructured":"Hundal R, Shaffer EA. Gallbladder cancer: epidemiology and outcome. Clin Epidemiol. 2014;6:99\u2013109. https:\/\/doi.org\/10.2147\/CLEP.S37357. Published 2014 Mar 7.","journal-title":"Clin Epidemiol"},{"issue":"6","key":"1425_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","volume":"51","author":"EC Lazcano-Ponce","year":"2001","unstructured":"Lazcano-Ponce EC, Miquel JF, Mu\u00f1oz N, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51(6):349\u201364. https:\/\/doi.org\/10.3322\/canjclin.51.6.349.","journal-title":"CA Cancer J Clin"},{"issue":"43","key":"1425_CR4","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.3748\/wjg.v16.i43.5395","volume":"16","author":"G Nath","year":"2010","unstructured":"Nath G, Gulati AK, Shukla VK. Role of bacteria in carcinogenesis, with special reference to carcinoma of the gallbladder. World J Gastroenterol. 2010;16(43):5395\u2013404. https:\/\/doi.org\/10.3748\/wjg.v16.i43.5395.","journal-title":"World J Gastroenterol"},{"key":"1425_CR5","doi-asserted-by":"publisher","unstructured":"Elgenidy A, Odat RM, Al-Ghorbany HA, et al. Arsenic\u2019s shadowy influence: A systematic review of its carcinogenic role in gallbladder cancer. J Hepatobiliary Pancreat Sci Published Online April. 2024;1. https:\/\/doi.org\/10.1002\/jhbp.1428.","DOI":"10.1002\/jhbp.1428"},{"issue":"2","key":"1425_CR6","first-page":"41","volume":"5","author":"P Gupta","year":"2012","unstructured":"Gupta P, Agarwal A, Gupta V, Singh PK, Pantola C, Amit S. Expression and clinicopathological significance of Estrogen and progesterone receptors in gallbladder cancer. Gastrointest Cancer Res. 2012;5(2):41\u20137.","journal-title":"Gastrointest Cancer Res"},{"issue":"4","key":"1425_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/00008469-200508000-00011","volume":"14","author":"U Dutta","year":"2005","unstructured":"Dutta U, Nagi B, Garg PK, Sinha SK, Singh K, Tandon RK. Patients with gallstones develop gallbladder cancer at an earlier age. Eur J Cancer Prev. 2005;14(4):381\u20135. https:\/\/doi.org\/10.1097\/00008469-200508000-00011.","journal-title":"Eur J Cancer Prev"},{"issue":"4","key":"1425_CR8","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/j.suronc.2012.08.002","volume":"21","author":"C Boutros","year":"2012","unstructured":"Boutros C, Gary M, Baldwin K, Somasundar P. Gallbladder cancer: past, present and an uncertain future. Surg Oncol. 2012;21(4):e183\u201391. https:\/\/doi.org\/10.1016\/j.suronc.2012.08.002.","journal-title":"Surg Oncol"},{"issue":"1","key":"1425_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12957-022-02857-y","volume":"20","author":"Z Feroz","year":"2022","unstructured":"Feroz Z, Gautam P, Tiwari S, Shukla GC, Kumar M. Survival analysis and prognostic factors of the carcinoma of gallbladder. World J Surg Oncol. 2022;20(1):403. https:\/\/doi.org\/10.1186\/s12957-022-02857-y. Published 2022 Dec 20.","journal-title":"World J Surg Oncol"},{"issue":"6","key":"1425_CR10","doi-asserted-by":"publisher","first-page":"695","DOI":"10.5306\/wjco.v15.i6.695","volume":"15","author":"A Kumar","year":"2024","unstructured":"Kumar A, Sarangi Y, Gupta A, Sharma A. Gallbladder cancer: progress in the Indian Subcontinent. World J Clin Oncol. 2024;15(6):695\u2013716. https:\/\/doi.org\/10.5306\/wjco.v15.i6.695.","journal-title":"World J Clin Oncol"},{"issue":"8","key":"1425_CR11","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/jso.20535","volume":"93","author":"SS Sikora","year":"2006","unstructured":"Sikora SS, Singh RK. Surgical strategies in patients with gallbladder cancer: nihilism to optimism. J Surg Oncol. 2006;93(8):670\u201381. https:\/\/doi.org\/10.1002\/jso.20535.","journal-title":"J Surg Oncol"},{"issue":"4","key":"1425_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.21037\/cco.2019.07.02","volume":"8","author":"E Suzuki","year":"2019","unstructured":"Suzuki E, Bridgewater J. Adjuvant therapy for resected gallbladder cancer. Chin Clin Oncol. 2019;8(4):39. https:\/\/doi.org\/10.21037\/cco.2019.07.02.","journal-title":"Chin Clin Oncol"},{"issue":"9","key":"1425_CR13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.hpb.2018.03.008","volume":"20","author":"VA Chaudhari","year":"2018","unstructured":"Chaudhari VA, Ostwal V, Patkar S, et al. Outcome of neoadjuvant chemotherapy in locally advanced\/borderline resectable gallbladder cancer: the need to define indications. HPB (Oxford). 2018;20(9):841\u20137. https:\/\/doi.org\/10.1016\/j.hpb.2018.03.008.","journal-title":"HPB (Oxford)"},{"issue":"5","key":"1425_CR14","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019;20(5):663\u201373. https:\/\/doi.org\/10.1016\/S1470-2045(18)30915-X.","journal-title":"Lancet Oncol"},{"issue":"8","key":"1425_CR15","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s11605-017-3440-z","volume":"21","author":"TB Tran","year":"2017","unstructured":"Tran TB, Norton JA, Ethun CG, et al. Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable? J Gastrointest Surg. 2017;21(8):1245\u201353. https:\/\/doi.org\/10.1007\/s11605-017-3440-z.","journal-title":"J Gastrointest Surg"},{"issue":"14","key":"1425_CR16","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381. https:\/\/doi.org\/10.1056\/NEJMoa0908721.","journal-title":"N Engl J Med"},{"issue":"5","key":"1425_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/jgh3.12906","volume":"7","author":"KM Adam","year":"2023","unstructured":"Adam KM, Abdelrahim EY, Doush WM, Abdelaziz MS. Clinical presentation and management modalities of gallbladder cancer in sudan: A single-center study. JGH Open. 2023;7(5):365\u201371. https:\/\/doi.org\/10.1002\/jgh3.12906. Published 2023 Apr 25.","journal-title":"JGH Open"},{"issue":"7","key":"1425_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/jso.21141","volume":"98","author":"A Duffy","year":"2008","unstructured":"Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at memorial Sloan-Kettering cancer centre (MSKCC). J Surg Oncol. 2008;98(7):485\u20139. https:\/\/doi.org\/10.1002\/jso.21141.","journal-title":"J Surg Oncol"},{"issue":"18","key":"1425_CR19","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.3748\/wjg.v28.i18.1996","volume":"28","author":"M Alarabiyat","year":"2022","unstructured":"Alarabiyat M, Raza SS, Isaac J, et al. Incidental gallbladder cancer diagnosis confers survival advantage irrespective of tumour stage and characteristics. World J Gastroenterol. 2022;28(18):1996\u20132007. https:\/\/doi.org\/10.3748\/wjg.v28.i18.1996.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1425_CR20","doi-asserted-by":"publisher","first-page":"113","DOI":"10.14701\/ahbps.24-223","volume":"29","author":"P Varshney","year":"2025","unstructured":"Varshney P, Baghmar S, Sirohi B, et al. Neoadjuvant treatment for incidental gallbladder cancer: A systematic review. Ann Hepatobiliary Pancreat Surg. 2025;29(2):113\u201320. https:\/\/doi.org\/10.14701\/ahbps.24-223.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"issue":"16suppl","key":"1425_CR21","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1200\/jco.2025.43.16_suppl.4007","volume":"43","author":"R Engineer","year":"2025","unstructured":"Engineer R, Goel M, Ostwal V, et al. A phase III randomized clinical trial evaluating perioperative therapy (neoadjuvant chemotherapy versus chemoradiotherapy) in locally advanced gallbladder cancers (POLCAGB). J Clin Oncol. 2025;43(16suppl):4007\u20134007. https:\/\/doi.org\/10.1200\/jco.2025.43.16_suppl.4007.","journal-title":"J Clin Oncol"},{"key":"1425_CR22","doi-asserted-by":"publisher","first-page":"107786","DOI":"10.1016\/j.compbiomed.2023.107786","volume":"168","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang Q, Liang K, et al. Deep learning nomogram for preoperative distinction between xanthogranulomatous cholecystitis and gallbladder carcinoma: A novel approach for surgical decision. Comput Biol Med. 2024;168:107786. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107786.","journal-title":"Comput Biol Med"},{"issue":"3","key":"1425_CR23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1007\/s13193-016-0553-x","volume":"8","author":"A Chauhan","year":"2017","unstructured":"Chauhan A, Ganguly M, Sharma AK. Isolated Port site metastases in carcinoma gallbladder: does it represent better prognosis? Indian J Surg Oncol. 2017;8(3):258\u201362. https:\/\/doi.org\/10.1007\/s13193-016-0553-x.","journal-title":"Indian J Surg Oncol"},{"issue":"12","key":"1425_CR24","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/annonc\/mdz402","volume":"30","author":"C Morizane","year":"2019","unstructured":"Morizane C, Okusaka T, Mizusawa J, et al. Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced\/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial. Ann Oncol. 2019;30(12):1950\u20138. https:\/\/doi.org\/10.1093\/annonc\/mdz402.","journal-title":"Ann Oncol"},{"key":"1425_CR25","doi-asserted-by":"publisher","unstructured":"Oh DY, He AR, Qin S, et al. Durvalumab plus chemotherapy in advanced biliary tract cancer: 3-year overall survival update from the phase III TOPAZ-1 study. J Hepatol Published Online May. 2025;15. https:\/\/doi.org\/10.1016\/j.jhep.2025.05.003.","DOI":"10.1016\/j.jhep.2025.05.003"},{"issue":"5","key":"1425_CR26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1470-2045(21)00027-9","volume":"22","author":"A Lamarca","year":"2021","unstructured":"Lamarca A, Palmer DH, Wasan HS, et al. Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial. Lancet Oncol. 2021;22(5):690\u2013701. https:\/\/doi.org\/10.1016\/S1470-2045(21)00027-9.","journal-title":"Lancet Oncol"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01425-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01425-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01425-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T15:05:05Z","timestamp":1771859105000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01425-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1425"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01425-x","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,23]]},"assertion":[{"value":"2 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval was taken from Institutional ethics committee, MPMMCC and HBCH, Varanasi, India. Approval number- OIEC\/11000652\/2023\/00003.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}